Keeping our communities safe and healthy
is our highest priority

FDA Approves First COVID-19 Vaccine, Pfizer

The U.S. Food and Drug Administration approved the first COVID-19 vaccine Monday, August 23, 2021. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.

Read more

    The delta variant of the coronavirus appears to cause more severe illness than earlier variants and spreads as easily as chickenpox, according to an internal federal health document that argues officials must “acknowledge the war has changed.”

    Read more

      How Immunity Generated from COVID-19 Vaccines Differs from an Infection 

      The new evidence shows that protective antibodies generated in response to an mRNA vaccine will target a broader range of SARS-CoV-2 variants carrying “single letter” changes in a key portion of their spike protein compared to antibodies acquired from an infection.

      These results add to evidence that people with acquired immunity may have differing levels of protection to emerging SARS-CoV-2 variants. More importantly, the data provide further documentation that those who’ve had and recovered from a COVID-19 infection still stand to benefit from getting vaccinated.

      Read more

        Credit for Moderna's COVID-19 vaccine belongs in part to discoveries dating back 15 years. The team behind it was inspired by two infant deaths. Click to read more.

        Association for Professionals in Infection Control and Epidemiology (APIC) among long list of Medical Groups Calling for Mandatory Vaccination for Healthcare Workers 

        Read statement

          COVID-19 (coronavirus): Long-term effects

          Most people who have coronavirus disease 2019 (COVID-19) recover completely within a few weeks. But some people — even those who had mild versions of the disease — continue to experience symptoms after their initial recovery. These people sometimes describe themselves as "long haulers" and the conditions have been called post-COVID-19 syndrome or "long COVID-19." These health issues are sometimes called post-COVID-19 conditions. They're generally considered to be effects of COVID-19 that persist for more than four weeks after you've been diagnosed with the COVID-19 virus.

          Learn more

            FDA Approves First COVID-19 Vaccine, Pfizer

            Posted on: Aug 23, 2021

            Today [August 23], the U.S. Food and Drug Administration approved the...

            Read More

            Dr. Monique Williams discusses the Delta Variant and Covid-19 Vaccine

            Posted on: Sep 01, 2021

            Dr. Monique Williams, a member of the St. Louis County Public Health...

            Read More

            Joint Statement in Support of COVID-19 Vaccine Mandates for All Workers in Health Care

            Posted on: Jul 28, 2021

            Association for Professionals in Infection Control and Epidemiology (APIC)...

            Read More